Skip to content
HowShorted

Zosano Pharma Corp short interest in 2019

In 2019, Zosano Pharma Corp's disclosed short interest ran from 11.21% of shares outstanding on 15 Jan 2019 to 13.30% on 31 Dec 2019, a change of +2.09 percentage points. The year's high was 20.54% on 30 Apr 2019 and its low 9.13% on 15 Oct 2019, averaging 12.49% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.53 days on 15 Jan 2019. Full history: Zosano Pharma Corp.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022

Aggregate net short position time series for Zosano Pharma Corp in 2019

2019 in figures

Start of year
11.21% (15 Jan 2019)
End of year
13.30% (31 Dec 2019)
Change
+2.09 pp
High
20.54% (30 Apr 2019)
Low
9.13% (15 Oct 2019)
Average
12.49%
Highest days to cover
13.53 (15 Jan 2019)
SEC filings marked
8

Every report in 2019

Zosano Pharma Corp short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 201911.21%13.53
31 Jan 201910.93%8.33
15 Feb 201910.73%8.11
28 Feb 201916.77%1.00
15 Mar 201915.58%1.25results (8-K)
29 Mar 201916.49%2.7710-K filed
15 Apr 201916.61%2.12
30 Apr 201920.54%3.01
15 May 201912.65%4.4110-Q filed, results (8-K)
31 May 201911.23%2.69
14 Jun 201911.99%7.87
28 Jun 201911.75%4.50
15 Jul 201912.07%5.34
31 Jul 201911.36%6.87
15 Aug 20199.29%6.7910-Q filed, results (8-K)
30 Aug 201910.08%4.23
13 Sep 201910.39%6.66
30 Sep 201910.49%6.07
15 Oct 20199.13%5.00
31 Oct 201911.87%6.94
15 Nov 201911.60%11.7410-Q filed, results (8-K)
29 Nov 201912.67%5.46
13 Dec 201910.98%4.94
31 Dec 201913.30%4.10

See also: Zosano Pharma Corp's full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.